444 related articles for article (PubMed ID: 16738325)
1. An ATR- and BRCA1-mediated Fanconi anemia pathway is required for activating the G2/M checkpoint and DNA damage repair upon rereplication.
Zhu W; Dutta A
Mol Cell Biol; 2006 Jun; 26(12):4601-11. PubMed ID: 16738325
[TBL] [Abstract][Full Text] [Related]
2. Proteasome function is required for DNA damage response and fanconi anemia pathway activation.
Jacquemont C; Taniguchi T
Cancer Res; 2007 Aug; 67(15):7395-405. PubMed ID: 17671210
[TBL] [Abstract][Full Text] [Related]
3. Activation of fanconi anemia pathway in cells with re-replicated DNA.
Zhu W; Dutta A
Cell Cycle; 2006 Oct; 5(20):2306-9. PubMed ID: 17102625
[TBL] [Abstract][Full Text] [Related]
4. Upregulated ATM gene expression and activated DNA crosslink-induced damage response checkpoint in Fanconi anemia: implications for carcinogenesis.
Yamamoto K; Nihrane A; Aglipay J; Sironi J; Arkin S; Lipton JM; Ouchi T; Liu JM
Mol Med; 2008; 14(3-4):167-74. PubMed ID: 18224251
[TBL] [Abstract][Full Text] [Related]
5. Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48.
Velimezi G; Robinson-Garcia L; Muñoz-Martínez F; Wiegant WW; Ferreira da Silva J; Owusu M; Moder M; Wiedner M; Rosenthal SB; Fisch KM; Moffat J; Menche J; van Attikum H; Jackson SP; Loizou JI
Nat Commun; 2018 Jun; 9(1):2280. PubMed ID: 29891926
[TBL] [Abstract][Full Text] [Related]
6. The interplay of Fanconi anemia proteins in the DNA damage response.
Wang X; D'Andrea AD
DNA Repair (Amst); 2004; 3(8-9):1063-9. PubMed ID: 15279794
[TBL] [Abstract][Full Text] [Related]
7. Loss of CHK1 function impedes DNA damage-induced FANCD2 monoubiquitination but normalizes the abnormal G2 arrest in Fanconi anemia.
Guervilly JH; Macé-Aimé G; Rosselli F
Hum Mol Genet; 2008 Mar; 17(5):679-89. PubMed ID: 18029388
[TBL] [Abstract][Full Text] [Related]
8. FANCD2 Binds Human Papillomavirus Genomes and Associates with a Distinct Set of DNA Repair Proteins to Regulate Viral Replication.
Spriggs CC; Laimins LA
mBio; 2017 Feb; 8(1):. PubMed ID: 28196964
[TBL] [Abstract][Full Text] [Related]
9. ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.
Collins NB; Wilson JB; Bush T; Thomashevski A; Roberts KJ; Jones NJ; Kupfer GM
Blood; 2009 Mar; 113(10):2181-90. PubMed ID: 19109555
[TBL] [Abstract][Full Text] [Related]
10. The ATR-mediated S phase checkpoint prevents rereplication in mammalian cells when licensing control is disrupted.
Liu E; Lee AY; Chiba T; Olson E; Sun P; Wu X
J Cell Biol; 2007 Nov; 179(4):643-57. PubMed ID: 18025301
[TBL] [Abstract][Full Text] [Related]
11. Fanconi anemia pathway-deficient tumor cells are hypersensitive to inhibition of ataxia telangiectasia mutated.
Kennedy RD; Chen CC; Stuckert P; Archila EM; De la Vega MA; Moreau LA; Shimamura A; D'Andrea AD
J Clin Invest; 2007 May; 117(5):1440-9. PubMed ID: 17431503
[TBL] [Abstract][Full Text] [Related]
12. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
[TBL] [Abstract][Full Text] [Related]
13. A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint.
Freie BW; Ciccone SL; Li X; Plett PA; Orschell CM; Srour EF; Hanenberg H; Schindler D; Lee SH; Clapp DW
J Biol Chem; 2004 Dec; 279(49):50986-93. PubMed ID: 15377654
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 tumor suppressors protect against endogenous acetaldehyde toxicity.
Tacconi EM; Lai X; Folio C; Porru M; Zonderland G; Badie S; Michl J; Sechi I; Rogier M; Matía García V; Batra AS; Rueda OM; Bouwman P; Jonkers J; Ryan A; Reina-San-Martin B; Hui J; Tang N; Bruna A; Biroccio A; Tarsounas M
EMBO Mol Med; 2017 Oct; 9(10):1398-1414. PubMed ID: 28729482
[TBL] [Abstract][Full Text] [Related]
15. BRCA1 Is Required for Maintenance of Phospho-Chk1 and G2/M Arrest during DNA Cross-Link Repair in DT40 Cells.
Draga M; Madgett EB; Vandenberg CJ; du Plessis D; Kaufmann A; Werler P; Chakraborty P; Lowndes NF; Hiom K
Mol Cell Biol; 2015 Nov; 35(22):3829-40. PubMed ID: 26324327
[TBL] [Abstract][Full Text] [Related]
16. A major switch for the Fanconi anemia DNA damage-response pathway.
Wang W
Nat Struct Mol Biol; 2008 Nov; 15(11):1128-30. PubMed ID: 18985065
[No Abstract] [Full Text] [Related]
17. Human syndromes with genomic instability and multiprotein machines that repair DNA double-strand breaks.
De la Torre C; Pincheira J; López-Sáez JF
Histol Histopathol; 2003 Jan; 18(1):225-43. PubMed ID: 12507302
[TBL] [Abstract][Full Text] [Related]
18. The Fanconi anaemia genome stability and tumour suppressor network.
Bogliolo M; Cabré O; Callén E; Castillo V; Creus A; Marcos R; Surrallés J
Mutagenesis; 2002 Nov; 17(6):529-38. PubMed ID: 12435850
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-mediated G2/M cell cycle arrest requires ERK1/2 kinase activation.
Yan Y; Spieker RS; Kim M; Stoeger SM; Cowan KH
Oncogene; 2005 May; 24(20):3285-96. PubMed ID: 15735702
[TBL] [Abstract][Full Text] [Related]
20. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks.
Sobeck A; Stone S; Costanzo V; de Graaf B; Reuter T; de Winter J; Wallisch M; Akkari Y; Olson S; Wang W; Joenje H; Christian JL; Lupardus PJ; Cimprich KA; Gautier J; Hoatlin ME
Mol Cell Biol; 2006 Jan; 26(2):425-37. PubMed ID: 16382135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
